I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...
About
AI in Pharmacovigilance Signal Detection and Management (ML and NLP) training provides a practical overview of applying Artificial Intelligence, Machine Learning, and Natural Language Processing to pharmacovigilance signal detection and management while maintaining scientific rigor, human oversight, data integrity, and regulatory compliance.
This AI in Pharmacovigilance Signal Detection and Management Course & Certification provides essential knowledge on AI-assisted signal detection, machine learning-based signal triage and prioritization, disproportionality analysis, NLP-based extraction from safety narratives, automated coding, data quality, model performance, validation, bias, explainability, human-in-the-loop review, signal validation, clinical assessment, model monitoring, change control, documentation, and AI governance. Learners will understand how AI outputs should be interpreted as candidate signals or predictions rather than evidence of causality, and how human reviewers remain accountable for validation, assessment, prioritization, and signal-management decisions. Upon successful completion, learners receive a certification demonstrating their understanding of responsible and compliant use of AI, ML, and NLP in pharmacovigilance signal detection and management.
- Pharmacovigilance and Drug Safety Professionals
- Signal Detection and Signal Management Teams
- Medical Reviewers and Safety Physicians
- Clinical Data Scientists and Pharmacovigilance Data Analysts
- AI, Machine Learning, and NLP Professionals working in Pharmacovigilance
- Regulatory Affairs and Quality Assurance Professionals
- Pharmacovigilance Compliance and Audit Professionals
- Safety Information and Case Processing Teams
- Pharmacovigilance Managers and Project Leads
- Anyone involved in evaluating, implementing, governing, or overseeing AI-assisted pharmacovigilance processes
What you will learn
Understand the fundamentals of Artificial Intelligence (AI), Machine Learning (ML), and Natural Language Processing (NLP) and how they can be applied to pharmacovigilance signal detection and management within a GVP-compliant environment.
Learn how AI and ML support signal triage, candidate ranking, disproportionality analysis, prioritization, and detection of potential safety signals, while understanding model performance, data quality, bias, and the limitations of automated outputs.
Develop practical knowledge of NLP applications in pharmacovigilance, including safety narrative extraction, negation and ambiguity handling, automated coding, case-level review, human-in-the-loop validation, and the distinction between AI predictions and confirmed safety signals.
Gain an understanding of AI validation, explainability, model monitoring, change control, documentation, data confidentiality, audit trails, human accountability, and regulatory expectations for using AI-assisted approaches in pharmacovigilance signal management.
Course Syllabus
- The signal-management lifecycle
- What a signal is (and is not)
- Where AI can augment each stage
- Augment, not replace - human accountability
- Observed vs expected and the 2x2 table
- PRR, ROR, EBGM and the Information Component
- Thresholds as conventions, not law
- The limits that open the door to ML
- Supervised, unsupervised and temporal methods
- Classifiers for triage; features and labels
- Class imbalance and data leakage
- TriageML vs disproportionality on the same data
- Why unstructured text matters
- The NLP extraction pipeline
- Where NLP fails: negation, temporality, ambiguity
- Confidentiality and enterprise-vs-public tooling
- MedDRA hierarchy and coding's role
- How automated coding works; confidence routing
- Grouping: PTs, HLTs and SMQs
- Version dependence and reproducibility
- Precision, recall and F1
- Thresholds and the missed-signal cost
- Prediction is not causation; no signal is not no risk
- Bias, fairness and calibration
- Sources and their biases
- Duplicates, masking and confounding
- A masked/confounded worked example
- Reproducibility: data, model, version, seed
- Intended use drives validation
- GAMP 5, CSA and Annex 11 / 21 CFR Part 11
- ISO/IEC 42001 and CIOMS XIV governance
- Ongoing monitoring, drift and change control
- From flag to validation
- Prioritisation as a separate decision
- Assessment integrates all evidence
- Bradford Hill, benefit-risk and the review worksheet
- What inspectors ask about AI
- Documentation, ALCOA+ and model cards
- Communicating AI-assisted findings
- Capstone investigation and the future
- The signal-management lifecycle recap
- Prediction is not causation; no signal is not no risk
- 📘 Bonus: AI in Pharmacovigilance Signal Detection and Management (ML and NLP) eBook (Free with purchase)







